Effects of estrogen receptor antagonist on biological behavior and expression of growth factors in the prolactinoma MMQ cell line
β Scribed by Hongtao Lv; Chuzhong Li; Songbai Gui; Meizhen Sun; Dan Li; Yazhuo Zhang
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 474 KB
- Volume
- 102
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Type beta transforming growth factor (B-TGF) is a potent growth inhibitor to many human tumor cell lines. Very little is known about the mechanism for this growth inhibitory action of B-TGF. We here report the effect of B-TGF on proliferation and epidermal growth factor receptor (R-EGF) expression i
Previously, it has been shown that the binding of epidermal growth factor (EGF) by a wide range of cells decreases as cell density increases. In this report, we demonstrate that KB cells treated chronically with phorbol esters continue to exhibit decreases in EGF receptor binding as cell density inc
## Abstract In cultured human osteoblasts estradiolβ17Ξ² (E2) modulated DNA synthesis, the specific activity of creatine kinase BB (CK), 12 and 15 lipoxygenase (LO) mRNA expression and formation of 12β and 15βhydroxyeicosatetraenoic acid (HETE). We now investigate the response of human bone cell lin
The effect of tyrosine kinase inhibitor, erbstatin, on cell growth and mRNA expression of growth-factor/receptor system was examined in 6 human gastric-carcinoma cell lines. Erbstatin inhibited both EGF-induced and serum-stimulated cell growth of all 6 cell lines (TMK-I, MKN-I, -7, -28, -45, -74) in